1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Arrhythmia: new trials by email Literature Review of Arrhythmia trials Research Report on Arrhythmia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients Control group:DH001 placebo, Trial group: DH001 low-dose group, Trial group: DH001 high-dose group - Cancer, Heart Failure | Phase 2 | Unknown | Monyan Pharmaceutical (Shanghai) Co., Ltd. | 90 | 2023-04-04 | 2023-10-23 |
Arrhythmias, Cardiac (1) · Heart Failure (1) · Neoplasms (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Control Groups (1) · Population Groups (1)
Monyan Pharmaceutical (Shanghai) Co., Ltd. (1)
China (1)
Hesheng He (1) · Hongmei Jing (1) · Hui Zhou (1) · Jiwei Liu (1) · Jun Zhu (1) · Wenbin Qian (1) · Xiaojia Wang (1) · Yufu Li (1) · Zeping Zhou (1) · Zhenchang Sun (1)